% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Soch:272890,
author = {Soch, Joram and Richter, Anni and Kizilirmak, Jasmin M and
Schütze, Hartmut and Ziegler, Gabriel and Altenstein,
Slawek and Brosseron, Frederic and Dechent, Peter and
Fliessbach, Klaus and Freiesleben, Silka Dawn and Glanz,
Wenzel and Gref, Daria and Heneka, Michael and Hetzer,
Stefan and Incesoy, Enise I and Kilimann, Ingo and Kimmich,
Okka and Kleineidam, Luca and Kuhn, Elizabeth and Laske,
Christoph and Lohse, Andrea and Lüsebrink, Falk and Munk,
Matthias H and Peters, Oliver and Preis, Lukas and Priller,
Josef and Ramirez, Alfredo and Roeske, Sandra and
Rostamzadeh, Ayda and Roy-Kluth, Nina and Scheffler, Klaus
and Schmid, Matthias and Schneider, Anja and Spottke, Annika
and Spruth, Eike Jakob and Teipel, Stefan and Wiltfang, Jens
and Jessen, Frank and Wagner, Michael and Düzel, Emrah and
Schott, Björn H},
title = {{S}ingle-value brain activity scores reflect both severity
and risk across the {A}lzheimer's continuum.},
journal = {Brain},
volume = {147},
number = {11},
issn = {0006-8950},
address = {Oxford},
publisher = {Oxford Univ. Press},
reportid = {DZNE-2024-01303},
pages = {3789 - 3803},
year = {2024},
abstract = {Single-value scores reflecting the deviation from (FADE
score) or similarity with (SAME score) prototypical
novelty-related and memory-related functional MRI activation
patterns in young adults have been proposed as imaging
biomarkers of healthy neurocognitive ageing. Here, we tested
the utility of these scores as potential diagnostic and
prognostic markers in Alzheimer's disease (AD) and risk
states like mild cognitive impairment (MCI) or subjective
cognitive decline (SCD). To this end, we analysed subsequent
memory functional MRI data from individuals with SCD, MCI
and AD dementia as well as healthy controls and first-degree
relatives of AD dementia patients (AD-rel) who participated
in the multi-centre DELCODE study (n = 468). Based on the
individual participants' whole-brain functional MRI novelty
and subsequent memory responses, we calculated the FADE and
SAME scores and assessed their association with AD risk
stage, neuropsychological test scores, CSF amyloid
positivity and APOE genotype. Memory-based FADE and SAME
scores showed a considerably larger deviation from a
reference sample of young adults in the MCI and AD dementia
groups compared to healthy controls, SCD and AD-rel. In
addition, novelty-based scores significantly differed
between the MCI and AD dementia groups. Across the entire
sample, single-value scores correlated with
neuropsychological test performance. The novelty-based SAME
score further differed between Aβ-positive and Aβ-negative
individuals in SCD and AD-rel, and between ApoE ɛ4 carriers
and non-carriers in AD-rel. Hence, FADE and SAME scores are
associated with both cognitive performance and individual
risk factors for AD. Their potential utility as diagnostic
and prognostic biomarkers warrants further exploration,
particularly in individuals with SCD and healthy relatives
of AD dementia patients.},
keywords = {Humans / Alzheimer Disease: genetics / Alzheimer Disease:
psychology / Alzheimer Disease: physiopathology / Male /
Female / Aged / Magnetic Resonance Imaging / Cognitive
Dysfunction: physiopathology / Brain: diagnostic imaging /
Middle Aged / Neuropsychological Tests / Severity of Illness
Index / Adult / Aged, 80 and over / Apolipoproteins E:
genetics / Alzheimer’s disease (Other) / dementia risk
(Other) / fMRI scores (Other) / mild cognitive impairment
(Other) / novelty processing (Other) / subsequent memory
(Other) / Apolipoproteins E (NLM Chemicals)},
cin = {AG Fischer / Clinical Dementia Research (Göttingen) / AG
Wiltfang / AG Düzel / AG Endres / AG Heneka / Patient
Studies (Bonn) / AG Peters / AG Teipel / Clinical Research
(Bonn) / AG Wagner / AG Gasser / AG Spottke / AG Schmid Bonn
/ AG Schneider / AG Jessen},
ddc = {610},
cid = {I:(DE-2719)1410002 / I:(DE-2719)1440015 /
I:(DE-2719)1410006 / I:(DE-2719)5000006 / I:(DE-2719)1811005
/ I:(DE-2719)1011303 / I:(DE-2719)1011101 /
I:(DE-2719)5000000 / I:(DE-2719)1510100 / I:(DE-2719)1011001
/ I:(DE-2719)1011201 / I:(DE-2719)1210000 /
I:(DE-2719)1011103 / I:(DE-2719)1013028 / I:(DE-2719)1011305
/ I:(DE-2719)1011102},
pnm = {352 - Disease Mechanisms (POF4-352) / 353 - Clinical and
Health Care Research (POF4-353)},
pid = {G:(DE-HGF)POF4-352 / G:(DE-HGF)POF4-353},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:38743817},
pmc = {pmc:PMC11531847},
doi = {10.1093/brain/awae149},
url = {https://pub.dzne.de/record/272890},
}